Nuclear receptor subfamily 4 group A member 1
AltitudeomicsDB
Protein Official symbol |
NR4A1 |
Aliases |
NR4A1 GFRP1 HMR NAK1 |
Chromosomal Location |
12 |
Length |
598 |
Uniprot ID |
P22736 |
EC number |
None |
Protein family Information(Pfam) |
PF00104;PF00105; |
PDB id |
2QW4;3V3E;3V3Q;4JGV;4KZI;4KZJ;4KZM;4RE8;4REE;4REF;4RZE;4RZF;4RZG;4WHF;4WHG;6LC1; |
InterPro ID |
IPR035500;IPR003071;IPR003070;IPR000536;IPR001723;IPR001628;IPR013088; |
dbSNP |
rs1882118 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
RXRA |
MED1 |
0.989 |
MEF2D |
EP300 |
0.988 |
AKT1 |
NR4A1 |
0.984 |
AKT1 |
AKT2 |
0.983 |
MAPK7 |
MEF2D |
0.977 |
AKT1 |
EP300 |
0.976 |
RXRA |
EP300 |
0.975 |
RXRG |
MED1 |
0.968 |
NR4A1 |
MEF2D |
0.968 |
RXRA |
RXRG |
0.967 |
RXRB |
MED1 |
0.967 |
AKT1 |
MEF2D |
0.961 |
NR4A1 |
BCL2 |
0.958 |
NR4A1 |
EP300 |
0.955 |
MED1 |
EP300 |
0.955 |
NR4A1 |
MAPK1 |
0.951 |
NR4A1 |
RXRA |
0.95 |
NR4A1 |
NFATC1 |
0.949 |
BCL2 |
MAPK1 |
0.945 |
NR4A1 |
RXRG |
0.942 |
AKT1 |
BCL2 |
0.941 |
RXRA |
MAPK1 |
0.941 |
NR4A1 |
MED1 |
0.94 |
AKT1 |
AKT3 |
0.931 |
AKT1 |
RXRA |
0.93 |
NFATC1 |
MEF2D |
0.929 |
NR4A1 |
MAPK7 |
0.927 |
NR4A1 |
RXRB |
0.921 |
AKT1 |
RXRB |
0.912 |
AKT2 |
AKT3 |
0.909 |
AKT1 |
RXRG |
0.908 |
RXRB |
MAPK1 |
0.907 |
BCL2 |
EP300 |
0.907 |
NR4A1 |
AKT2 |
0.906 |
MAPK7 |
MAPK1 |
0.906 |
RXRA |
RXRB |
0.905 |
AKT1 |
MAPK1 |
0.905 |
RXRG |
MAPK1 |
0.904 |
BCL2 |
RXRB |
0.904 |
NR4A1 |
AKT3 |
0.903 |
RXRB |
RXRG |
0.903 |
RXRA |
BCL2 |
0.902 |
BCL2 |
RXRG |
0.902 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
6256 (RXRA) |
4209 (MEF2D) |
207 (AKT1) |
5598 (MAPK7) |
6258 (RXRG) |
3164 (NR4A1) |
6257 (RXRB) |
5469 (MED1) |
596 (BCL2) |
4772 (NFATC1) |
208 (AKT2) |
2033 (EP300) |
5594 (MAPK1) |
10000 (AKT3) |
6256 (RXRA)
|
1.00
|
0.70
|
0.44
|
0.43
|
0.55
|
0.77
|
0.77
|
0.78
|
0.60
|
0.67
|
0.42
|
0.57
|
0.43
|
0.41
|
4209 (MEF2D)
|
0.70
|
1.00
|
0.42
|
0.41
|
0.71
|
0.84
|
0.82
|
0.63
|
0.53
|
0.84
|
0.40
|
0.50
|
0.41
|
0.38
|
207 (AKT1)
|
0.44
|
0.42
|
1.00
|
0.69
|
0.45
|
0.42
|
0.37
|
0.45
|
0.57
|
0.43
|
0.76
|
0.47
|
0.77
|
0.79
|
5598 (MAPK7)
|
0.43
|
0.41
|
0.69
|
1.00
|
0.50
|
0.41
|
0.35
|
0.46
|
0.53
|
0.47
|
0.77
|
0.43
|
0.88
|
0.79
|
6258 (RXRG)
|
0.55
|
0.71
|
0.45
|
0.50
|
1.00
|
0.63
|
0.72
|
0.54
|
0.57
|
0.67
|
0.50
|
0.41
|
0.47
|
0.44
|
3164 (NR4A1)
|
0.77
|
0.84
|
0.42
|
0.41
|
0.63
|
1.00
|
0.76
|
0.64
|
0.65
|
0.75
|
0.41
|
0.56
|
0.41
|
0.39
|
6257 (RXRB)
|
0.77
|
0.82
|
0.37
|
0.35
|
0.72
|
0.76
|
1.00
|
0.74
|
0.48
|
0.76
|
0.33
|
0.47
|
0.37
|
0.31
|
5469 (MED1)
|
0.78
|
0.63
|
0.45
|
0.46
|
0.54
|
0.64
|
0.74
|
1.00
|
0.53
|
0.66
|
0.45
|
0.64
|
0.46
|
0.44
|
596 (BCL2)
|
0.60
|
0.53
|
0.57
|
0.53
|
0.57
|
0.65
|
0.48
|
0.53
|
1.00
|
0.52
|
0.54
|
0.50
|
0.54
|
0.51
|
4772 (NFATC1)
|
0.67
|
0.84
|
0.43
|
0.47
|
0.67
|
0.75
|
0.76
|
0.66
|
0.52
|
1.00
|
0.42
|
0.53
|
0.42
|
0.40
|
208 (AKT2)
|
0.42
|
0.40
|
0.76
|
0.77
|
0.50
|
0.41
|
0.33
|
0.45
|
0.54
|
0.42
|
1.00
|
0.43
|
0.80
|
0.98
|
2033 (EP300)
|
0.57
|
0.50
|
0.47
|
0.43
|
0.41
|
0.56
|
0.47
|
0.64
|
0.50
|
0.53
|
0.43
|
1.00
|
0.48
|
0.43
|
5594 (MAPK1)
|
0.43
|
0.41
|
0.77
|
0.88
|
0.47
|
0.41
|
0.37
|
0.46
|
0.54
|
0.42
|
0.80
|
0.48
|
1.00
|
0.81
|
10000 (AKT3)
|
0.41
|
0.38
|
0.79
|
0.79
|
0.44
|
0.39
|
0.31
|
0.44
|
0.51
|
0.40
|
0.98
|
0.43
|
0.81
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
NR4A1 |
Toad |
Liver |
- |
3464 m |
33 day |
upregulated |
2.841386699 |
RNA-seq |
Tibetan Plateau |
Asiatic toad |
1 |
Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - |
28673260 |
NR4A1 |
Toad |
Heart |
- |
3464 m |
33 day |
downregulated |
-2.621215305 |
RNA-seq |
Tibetan Plateau |
Asiatic toad |
1 |
Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - |
28673260 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
3164 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GOTERM_BP_DIRECT |
3164 |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
GOTERM_BP_DIRECT |
3164 |
GO:0005654 |
nucleoplasm |
GOTERM_CC_DIRECT |
3164 |
GO:0007165 |
signal transduction |
GOTERM_BP_DIRECT |
3164 |
GO:0043401 |
steroid hormone mediated signaling pathway |
GOTERM_BP_DIRECT |
3164 |
GO:0045444 |
fat cell differentiation |
GOTERM_BP_DIRECT |
3164 |
GO:0003677 |
DNA binding |
GOTERM_MF_DIRECT |
3164 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
3164 |
GO:0003707 |
transcription factor activity |
GOTERM_MF_DIRECT |
3164 |
GO:0005737 |
cytoplasm |
GOTERM_CC_DIRECT |
3164 |
GO:0001938 |
positive regulation of endothelial cell proliferation |
GOTERM_BP_DIRECT |
3164 |
GO:0035767 |
endothelial cell chemotaxis |
GOTERM_BP_DIRECT |
3164 |
GO:0046982 |
protein heterodimerization activity |
GOTERM_MF_DIRECT |
3164 |
GO:0001077 |
transcriptional activator activity |
GOTERM_MF_DIRECT |
3164 |
GO:0004879 |
receptor activity |
GOTERM_MF_DIRECT |
3164 |
GO:0006915 |
apoptotic process |
GOTERM_BP_DIRECT |
3164 |
GO:0044344 |
cellular response to fibroblast growth factor stimulus |
GOTERM_BP_DIRECT |
3164 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
3164 |
GO:0043565 |
sequence-specific DNA binding |
GOTERM_MF_DIRECT |
3164 |
GO:0031965 |
nuclear membrane |
GOTERM_CC_DIRECT |
3164 |
GO:0043065 |
positive regulation of apoptotic process |
GOTERM_BP_DIRECT |
3164 |
GO:0002042 |
cell migration involved in sprouting angiogenesis |
GOTERM_BP_DIRECT |
3164 |
GO:0006351 |
transcription |
GOTERM_BP_DIRECT |
3164 |
GO:0005667 |
transcription factor complex |
GOTERM_CC_DIRECT |
3164 |
GO:0035924 |
cellular response to vascular endothelial growth factor stimulus |
GOTERM_BP_DIRECT |
3164 |
GO:0008270 |
zinc ion binding |
GOTERM_MF_DIRECT |
3164 |
GO:0035914 |
skeletal muscle cell differentiation |
GOTERM_BP_DIRECT |
3164 |
GO:0045786 |
negative regulation of cell cycle |
GOTERM_BP_DIRECT |
3164 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter |
GOTERM_BP_DIRECT |
3164 |
GO:0030522 |
intracellular receptor signaling pathway |
GOTERM_BP_DIRECT |
3164 |
GO:0061469 |
regulation of type B pancreatic cell proliferation |
GOTERM_BP_DIRECT |
3164 |
GO:0071376 |
cellular response to corticotropin-releasing hormone stimulus |
GOTERM_BP_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
3164 |
hsa04010 |
MAPK signaling pathway |
3164 |
hsa04151 |
PI3K-Akt signaling pathway |
3164 |
hsa04925 |
Aldosterone synthesis and secretion |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
NR4A1 |
3164 |
Endometrioma |
C0269102 |
Neoplastic Process |
0.3 |
0.558 |
0.621 |
disease |
NR4A1 |
3164 |
Myocardial Ischemia |
C0151744 |
Disease or Syndrome |
0.3 |
0.558 |
0.621 |
disease |
NR4A1 |
3164 |
Insulin Resistance |
C0021655 |
Pathologic Function |
0.3 |
0.558 |
0.621 |
phenotype |
NR4A1 |
3164 |
Proteinuria |
C0033687 |
Finding |
0.3 |
0.558 |
0.621 |
phenotype |
NR4A1 |
3164 |
Kidney Diseases |
C0022658 |
Disease or Syndrome |
0.3 |
0.558 |
0.621 |
group |
NR4A1 |
3164 |
Malignant neoplasm of pancreas |
C0346647 |
Neoplastic Process |
0.35 |
0.558 |
0.621 |
disease |
NR4A1 |
3164 |
Endometriosis |
C0014175 |
Disease or Syndrome |
0.3 |
0.558 |
0.621 |
disease |
NR4A1 |
3164 |
Insulin Sensitivity |
C0920563 |
Pathologic Function |
0.3 |
0.558 |
0.621 |
phenotype |
NR4A1 |
3164 |
Pancreatic Neoplasm |
C0030297 |
Neoplastic Process |
0.32 |
0.558 |
0.621 |
disease |